This means they are more expensive and therefore not as widely available in some countries, such as those with public health care systems compared to insurance-funded healthcare provision
For example, a 2024 review found that pyruvate promoted weight loss in some studies, but produced inconsistent results overall
According to altRx: "altRx patients typically experience 1-2 lbs per week weight loss after 4 weeks, combined with a healthy diet and exercise." The company further qualifies this statement with: "Based on average weight loss reported by patients without diabetes who reached and maintained a dose of 2.4 mg/week of GLP-1 treatment, alongside reduced calorie intake and increased physical activity." And the brand's qualifying language continues: "Results vary based on starting weight and program adherence
Lipotropic injections, although beneficial for many seeking weight loss and metabolic enhancement, are not suitable for everyone
Danhier F, Feron O, Prat V
states where Novi's services have been approved